Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 9,727Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Gowling WLG (Canada) LLP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

ABEMACICLIB

Brand Name : VERZENIO

Patent Number : 2747055

Filing Date : 2009-12-15

Strength per Unit : 50 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-12-15

Date Granted : 2014-01-14

blank

02

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

ABEMACICLIB

Brand Name : VERZENIO

Patent Number : 2747055

Filing Date : 2009-12-15

Strength per Unit : 100 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-12-15

Date Granted : 2014-01-14

blank

03

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

ABEMACICLIB

Brand Name : VERZENIO

Patent Number : 2747055

Filing Date : 2009-12-15

Strength per Unit : 150 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-12-15

Date Granted : 2014-01-14

blank

04

Gowling WLG (Canada) LLP

arrow
ChemOutsourcing
Not Confirmed

Gowling WLG (Canada) LLP

Country
arrow
ChemOutsourcing
Not Confirmed

ABEMACICLIB

Brand Name : VERZENIO

Patent Number : 2747055

Filing Date : 2009-12-15

Strength per Unit : 200 mg

Dosage Form : TABLET

Human Or VET : Human

Route of Administration : ORAL

Patent Expiration Date : 2029-12-15

Date Granted : 2014-01-14

blank